Lincoln Pharmaceuticals Ltd. | Small-cap | Healthcare
₹564.60
0.27%
| Lincoln Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 6.2B
Gross Profit 3.3B 53.26%
Operating Income 885.9M 14.22%
Net Income 823.5M 13.21%
EPS (Diluted) ₹41.11

Balance Sheet Metrics

Total Assets 8.0B
Total Liabilities 1.3B
Shareholders Equity 6.7B
Debt to Equity 0.19

Cash Flow Metrics

Operating Cash Flow 967.9M
Free Cash Flow 737.7M

Revenue & Profitability Trend

Lincoln Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 6.2B 5.7B 5.0B 4.7B 4.1B
Cost of Goods Sold 2.9B 2.8B 2.4B 2.2B 2.0B
Gross Profit 3.3B 2.9B 2.6B 2.5B 2.2B
Operating Expenses 1.2B 812.1M 724.8M 650.2M 647.4M
Operating Income 885.9M 896.2M 806.8M 884.0M 798.0M
Pre-tax Income 1.1B 1.2B 1.0B 959.4M 837.2M
Income Tax 268.4M 289.4M 275.8M 265.8M 214.7M
Net Income 823.5M 933.0M 729.0M 693.6M 622.5M
EPS (Diluted) ₹41.11 ₹46.58 ₹36.40 ₹34.63 ₹31.08

Income Statement Trend

Lincoln Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 5.0B 4.5B 3.7B 3.5B 3.1B
Non-Current Assets 3.0B 2.5B 2.2B 1.8B 1.4B
Total Assets 8.0B 7.0B 5.9B 5.3B 4.5B
Liabilities
Current Liabilities 1.1B 922.8M 721.5M 904.9M 758.4M
Non-Current Liabilities 191.2M 151.8M 128.0M 109.9M 101.3M
Total Liabilities 1.3B 1.1B 849.5M 1.0B 859.7M
Equity
Total Shareholders Equity 6.7B 5.9B 5.0B 4.3B 3.7B

Balance Sheet Composition

Lincoln Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 1.1B 1.2B 1.0B 959.4M 837.2M
Operating Cash Flow 967.9M 793.2M 845.1M 795.2M 787.6M
Investing Activities
Capital Expenditures -189.1M -393.9M -135.5M -454.5M -86.9M
Investing Cash Flow -488.4M -426.4M -179.6M -687.3M -530.8M
Financing Activities
Dividends Paid -36.1M -30.0M -30.0M -30.0M -
Financing Cash Flow -740.2M -248.1M -226.5M -15.2M -83.9M
Free Cash Flow 737.7M 236.0M 249.8M 306.1M 605.2M

Cash Flow Trend

Lincoln Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.59
Price to Book 1.66
Price to Sales 1.80
PEG Ratio -1.16

Profitability Ratios

Profit Margin 13.21%
Operating Margin 13.97%
Return on Equity 13.02%
Return on Assets 7.40%

Financial Health

Current Ratio 4.71
Debt to Equity 0.00
Beta 0.31

Per Share Data

EPS (TTM) ₹41.08
Book Value per Share ₹335.40
Revenue per Share ₹311.14

Financial data is updated regularly. All figures are in the company's reporting currency.